Moreover, siRNA screening reveals that several genes, such as PTEN-induced kinase 1 (PINK1) and Cysteine rich motor neuron 1 (CRIM1), may play drug-resistance roles in colorectal cancer cells when exposed to MEK inhibitor trametinib [13]. This evidence concerns the gene PINK1 and colorectal cancer.